All charts and data below are with dividends reinvested. (Inflation adjustment is OFF !)
| Fri 1980-03-28? to Tue 2025-09-02 |
YTD
Return |
TR
Price |
||||
|---|---|---|---|---|---|---|
| GSK × |
+19.11%
2025-09-02 |
342.66 TR
2025-09-02 |
||||
| GlaxoSmithKline PLC ADR NYSE Common Stock | ||||||
| Fri 1980-03-28? to Tue 2025-09-02 |
Overall
Return |
Exponential
Trendline |
||||
|---|---|---|---|---|---|---|
| GSK × |
+34,165.61%
+13.71%/yr |
+10.69%/yr
(R2=0.785) |
||||
| GlaxoSmithKline PLC ADR NYSE Common Stock | ||||||
| Fri 1980-03-28? to Tue 2025-09-02 |
Start
Value |
End
Value |
||||
|---|---|---|---|---|---|---|
| GSK × |
$10,000.00
1980-03-28 |
$3,426,561.13
2025-09-02 |
||||
| GlaxoSmithKline PLC ADR NYSE Common Stock | ||||||
| Year | GSK |
|---|---|
| 2025 (YTD) | +19.11% |
| 2024 | −5.14% |
| 2023 | +9.71% |
| 2022 | −16.77% |
| 2021 | +26.76% |
| 2020 | −17.71% |
| 2019 | +29.24% |
| 2018 | +13.79% |
| 2017 | −2.98% |
| 2016 | +2.10% |
| 2015 | −0.26% |
| 2014 | −15.69% |
| 2013 | +28.92% |
| 2012 | +0.65% |
| 2011 | +22.60% |
| 2010 | −2.12% |
| 2009 | +19.33% |
| 2008 | −22.26% |
| 2007 | −0.77% |
| 2006 | +7.94% |
| 2005 | +9.87% |
| 2004 | +5.61% |
| 2003 | +28.75% |
| 2002 | −21.59% |
| 2001 | −9.64% |
| 2000 | +4.16% |
| 1999 | −17.93% |
| 1998 | +48.18% |
| 1997 | +55.86% |
| 1996 | +17.92% |
| 1995 | +45.30% |
| 1994 | +3.08% |
| 1993 | −10.43% |
| 1992 | −22.91% |
| 1991 | +98.94% |
| 1990 | +30.45% |
| 1989 | +38.71% |
| 1988 | +6.99% |
| 1987 | +20.98% |
| 1986 | +44.00% |
| 1985 | +87.20% |
| 1984 | +31.17% |
| 1983 | −1.83% |
| 1982 | +158.74% |
| 1981 | +25.95% |
| 1980 | +25.07% |
| Fri 1980-03-28? to Tue 2025-09-02 |
Current
Drawdown |
Worst
Drawdown |
||||
|---|---|---|---|---|---|---|
| GSK × | −99.98% |
−100.00%
1985-09-30 |
||||
| GlaxoSmithKline PLC ADR NYSE Common Stock | ||||||